Shan, K.S.; Dalal, S.; Thaw Dar, N.N.; McLish, O.; Salzberg, M.; Pico, B.A. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. Int. J. Mol. Sci.2024, 25, 849.
Shan, K.S.; Dalal, S.; Thaw Dar, N.N.; McLish, O.; Salzberg, M.; Pico, B.A. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. Int. J. Mol. Sci. 2024, 25, 849.
Shan, K.S.; Dalal, S.; Thaw Dar, N.N.; McLish, O.; Salzberg, M.; Pico, B.A. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. Int. J. Mol. Sci.2024, 25, 849.
Shan, K.S.; Dalal, S.; Thaw Dar, N.N.; McLish, O.; Salzberg, M.; Pico, B.A. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. Int. J. Mol. Sci. 2024, 25, 849.
Abstract
Fibroblast growth factor receptors (FGFRs) are a family of receptor tyrosine kinases that involve in regulation of cell proliferation, survival, and development. FGFR alterations including amplifications, fusions, rearrangements, and mutations can result downstream activation of tyrosine kinases leading to tumor development. Targeting those FGFR alterations has shown to be effective in cholangiocarcinoma, urothelial carcinoma, and myeloid/lymphoid neoplasms and there are currently four FGFR inhibitors approved by the Food and Drug Administration (FDA). There have been developments of multiple agents targeting FGFR pathway including selective FGFR inhibitors, ligand traps, monoclonal antibodies, and antibody drug conjugates. However, most of these agents have variable and low responses with some intolerable toxicities and acquired resistances. This review will summarize previous clinical experiences and current developments of agents targeting FGFR pathway and discuss future directions of FGFR targeting agents.
Keywords
FGF; FGFR; targeted therapy; molecular profiling; precision medicine
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
